Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-044-2 | CAS number: 14970-87-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Start of experimental phase: 24 June 2016; End of experimental phase: 08 August 2016. Study completion:15 September 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- DMDO is a strong MTT reducer, this method is not suitable for its hazard identification.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted on 28 July 2015
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- 2,2'-[1,2-ethanediylbis(oxy)]bis(ethanethiol)
- EC Number:
- 239-044-2
- EC Name:
- 2,2'-[1,2-ethanediylbis(oxy)]bis(ethanethiol)
- Cas Number:
- 14970-87-7
- Molecular formula:
- C6H14O2S2
- IUPAC Name:
- 2,2'-[1,2-ethanediylbis(oxy)]bis(ethanethiol)
- Test material form:
- liquid
Constituent 1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- skin obtained from plastic surgery from a single donor
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- yes, concurrent MTT non-specific colour control
- Amount/concentration applied:
- The test item was applied as supplied in three replicates at the treatment level of 20 µL/epidermis unit, each measuring 0.38 cm2 (treatment level: 53 µL/cm2).
- Duration of treatment / exposure:
- An exposure time of 15 ± 0.5 minutes was allowed in a ventilated cabinet at room temperature.
Due to the non uniform distribution of the test item on the epidermidis, a redistribution on the treated tissues after an exposure time of 7 minutes was performed. - Duration of post-treatment incubation (if applicable):
- A 42 ± 1 hour recovery period was allowed by incubation at 37°C, 5 % CO2 and saturated humidity.
- Number of replicates:
- Negative control (live tissue): 3 replicates
Positive control (live tissue): 3 replicates
Test item (live tissue): 3 replicates
Negative control (killed tissue): 2 replicates
Test item (killed tissue): 2 replicates
Results and discussion
In vitro
Results
- Remarks on result:
- other: DMDO is a strong MTT reducer, this method is not suitable for its hazard identification.
- Other effects / acceptance of results:
- The mean cell viability of the test item, with only OD-blank subtraction, was 69 % of the concurrent negative control value, with an acceptable variability between replicates (SD of % viability = 6.3 lower than 18); however, the NSMTT control was 110 %, higher than the acceptability criteria stated in the OECD guideline n.439.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The potential of the test item to be irritant to the skin was investigated through an in vitro skin irritation study, using a commercial reconstructed human epidermis (RhE) model named EPISKIN™. The blank, negative and positive controls gave acceptable results and the study was accepted as valid. Since the test item is a strong MTT reducer, this method is not suitable for its hazard identification.
- Executive summary:
The potential of DMDO to be irritant to the skin was investigated through an in vitro skin irritation study using a commercial reconstructed human epidermis (RhE) model named EPISKIN™. The experimental procedures are based on the OECD Guideline for testing of chemicals no. 439. The test item, as well as controls, were tested for their ability to impair cell viability after an exposure period of 15 minutes followed by a 42 ± 1 hour recovery period. The final endpoint of the assay is the colorimetric measurement of MTT reduction (blue formazan salt) in the test system being this reaction an index of cell viability. The test item was tested as supplied by the Sponsor. Before the Main Assay, a preliminary test was carried out to evaluate the compatibility of the test item with the test system. In a first step, the test item was assayed for the ability of reducing MTT per se. A dark violet solution was noticed at the end of the incubation period, indicating that the test item can interact with MTT. Based on this result, an additional control was added in the Main Assay. In a second step, the test item was assayed for the ability of colouring water per se. No colour change was observed; spectral analysis of the test item in water, to evaluate the ability of the test chemical to absorb light at 595 nm, was performed. The value obtained for the Optical Density (OD) was 0.068, indicating that the test item does not have a potential interfering ability. In the Main Assay, the test item was applied as supplied in three replicates at the treatment level of 20 µL/epidermis unit, each measuring 0.38 cm2 (treatment level: 53 µL/cm2). Positive and negative controls [a 5 % (w/v) sodium dodecyl sulphate solution in water and Dulbecco’s phosphate buffered saline (D-PBS), respectively] were concurrently tested, in the same number of replicates and test conditions at the treatment level of 20 µL/epidermis unit. In order to verify if the test item results had to be corrected, the non specific MTT reduction (NSMTT) was evaluated using two killed tissues and compared with negative control performed with alive tissues. In the Main Assay, the negative control gave the expected baseline value (Optical Density values of the three replicates higher than 0.6) and variability [Standard Deviation (SD) of % viability lower or equal to 18], in agreement with the guideline indications. According to the method, the negative control mean value is considered the baseline value of the experiment and thus represents 100% of cell viability. The positive control caused the expected cell death (10.0 % of cell viability when compared to the negative control) and variability (SD of % viability equal to 0.5). Based on the stated criteria (mean viability = 40% and SD of % viability = 18), the assay was regarded as valid. The mean cell viability of the test item was 69 %, with an acceptable variability between replicates (SD of % Variability = 6.3). However, the NSMTT was 110 % of the concurrent negative control with alive tissues. This result indicated that the test item strongly interacts with MTT. These results do not allow a proper assessment of the irritation properties of the test item, indicating that the test method is not suitable for its hazard identification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.